CLINICAL_TRIALS
trial_result
· 2015-08-21
Clinical Trial Update: Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone [Phase 1]
Summary
A Phase 1 study comparing two formulations of opicapone in Parkinson disease to characterize single-dose pharmacokinetics and relative bioavailability, with res…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED | Results posted: 2015-08-21